ANIK PEER ANALYSIS

Anika Therapeutics Inc — metric-by-metric comparison with peers and the industry median

ANIKAnika Therapeutics Inc

🇺🇸 USA · NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic

Value it Duel

Overall Profile & Returns

· Drug Manufacturers - Specialty & Generic

Position Within Industry

0 = weak quartile, 100 = strong quartile

ANIKIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	ANIK	DEVA	TLRY	HLN	HIK	GENIL	Ind. Median
P/E	—	—	—	31.28	11.43●	46.82	21.37
P/B	1.55	0.51	0.33●	1.98	1.78	3.47	1.82
EV/EBITDA	—	6.74●	—	19.15	8.74	14.07	12.26
P/S	1.79	0.70	0.60●	3.94	1.37	1.86	2.09

Financial Health
Metric	ANIK	DEVA	TLRY	HLN	HIK	GENIL	Ind. Median
Current Ratio	4.46●	2.00	2.79	0.92	1.82	1.33	2.22
Debt/Equity	19.2%●	23.1%	20.4%	52.3%	61.8%	41.0%	46.3%
NetDebt/EBITDA	3.30	0.89	-0.07●	3.50	1.87	1.10	1.24

Profitability
Metric	ANIK	DEVA	TLRY	HLN	HIK	GENIL	Ind. Median
Net Margin	-9.5%	-4.4%	-158.8%	12.6%●	12.0%	4.0%	4.0%
ROE	-7.8%	-3.6%	-63.6%	6.3%	16.4%●	8.7%	6.4%
ROA	-6.0%	-2.5%	-49.7%	3.2%	7.5%●	4.8%	3.4%
EBITDA Margin	-4.0%	12.0%	-156.2%	25.2%●	20.0%	14.3%	18.2%

Growth + Dividend
Metric	ANIK	DEVA	TLRY	HLN	HIK	GENIL	Ind. Median
Rev. Growth	23.2%●	7.7%	3.8%	-26.7%	7.4%	16.3%	7.5%
NI Growth	—	—	—	-14.2%	12.2%	146.6%●	5.0%
Div. Yield	—	0.0%	—	2.0%	5.4%●	0.0%	2.0%
Payout	—	0.0%	—	40.0%	45.2%	0.0%	0.8%

Valuation
Metric	ANIK	SIGA	ASRT	ORGO	EOLS	EBS	Ind. Median
P/E	—	13.65	—	—	—	—	21.37
P/B	1.55	1.82	2.00	0.79	-15.63●	0.89	1.82
EV/EBITDA	—	4.79●	—	7.52	—	5.70	12.26
P/S	1.79	2.95	1.48	0.59●	1.49	0.69	2.09

Financial Health
Metric	ANIK	SIGA	ASRT	ORGO	EOLS	EBS	Ind. Median
Current Ratio	4.46●	3.25	1.82	3.53	2.04	4.29	2.22
Debt/Equity	19.2%	0.4%	53.3%	18.6%	-573.0%●	109.7%	46.3%
NetDebt/EBITDA	3.30	-5.27	5.39	-0.57	-8.20●	2.68	1.24

Profitability
Metric	ANIK	SIGA	ASRT	ORGO	EOLS	EBS	Ind. Median
Net Margin	-9.5%	21.6%●	-34.9%	-0.1%	-14.4%	-1.3%	4.0%
ROE	-7.8%	11.0%●	-38.8%	-0.1%	—	-1.6%	6.4%
ROA	-6.0%	8.7%●	-14.3%	-0.1%	-20.0%	-0.6%	3.4%
EBITDA Margin	-4.0%	29.3%●	-5.7%	7.3%	-4.6%	22.8%	18.2%

Growth + Dividend
Metric	ANIK	SIGA	ASRT	ORGO	EOLS	EBS	Ind. Median
Rev. Growth	23.2%●	-22.1%	-14.2%	11.9%	9.6%	-29.9%	7.5%
NI Growth	—	-58.2%	—	—	—	—	5.0%
Div. Yield	—	15.6%●	—	3.9%	—	—	2.0%
Payout	—	213.6%	—	-4,093.3%	—	—	0.8%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on ANIK

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 2, 26. This content is for informational purposes only and is not investment advice.